GILD has seen positive price action YTD; due to combatting the COVID-19 with their drug Remdesivir. Yesterday on the news, the trial on humans which was set in China to prove the effectivity of the drug, apparently "failed". However... The price just took us to the lower part of the channel , meaning the Risk-Reward-Ratio is at a good stance. A close below...
MRNA is the leading play on the COVID-19 vaccine list. The stock broke out above a beautiful bullish ascending triangle this month, and momentum continues to work in favor of the stock.
SO Moderna spiked from roughly $19.07 to $28 est. in less than 45 minutes after rumors broke into confirmations ending with headlines as Mordova has officially announced a vaccination for COVID-19 has been developed yet with months of red tape ahead of us (still have yet to undergo animal testing, clinical trials, human testing, then once the vaccination has been...
$MRNA is working on a vaccine for the coronavirus. If the stock breaks out above $36, it should take off. Risk looks to be minimal. The trade should work out right away. Can do buy stop at $36.01 and risk 20 to 50 cents, depending on your risk tolerance. Moderna, Inc., a clinical stage biotechnology company, develops therapeutics and vaccines based on messenger...
#Moderna is resting after break out. $36 is the critical resistance. watch for rsi and volume.
Moderna is one of the best pick for COVID-19 vaccine. They have already started dosing patients and expect the vaccine to be available for high-risk people like healthcare workers in the Fall this year. The strength is rising and needs to close above $36 by the end of next week.
Update from Moderna CEO tomorrow on current supply and R&D trials. Volatility dropping from highs.
This is a great example how forward looking indicators, when used in conjunction, can provide the most accurate support and resistance levels. While most indicators are lagging, projection indicators that help define major price pivots are predictive. MRNA ran into the upper MSP boundaries and has been trading between the bands with TDS lines from prior signals...
held GILD , MRNA calls over the weekend gilead only phase 3 coronavirus cure moderna first coronavirus vaccine
Technical RSI, MACD and momentum indicator (Lazybear) and chart looks like Moderna will be falling this week (8% +/- 5%) I plan to accumulate on dips into the $19 area while looking at charts. To confirm the formation of reverse head and shoulders, the nice symmetrical MACD and momentum swings with RSI reaching a bottom would confirm MRNA is poised to break...